Trump’s Trial Is Already Wreaking Havoc on His

New Post Public Reply Private Reply Replies (0) Message Board
Bhawks
198
Trump’s Trial Is Already Wreaking Havoc on His Campaign

THE DEFENSE IS RESTLESS

The hush money trial was never going to be good for Trump, but the first week in court proved just how disruptive and damaging it will be for his 2024 bid.


Jake Lahut Politics Reporter
Updated Apr. 19, 2024 7:03AM EDT Published Apr. 19, 2024 4:48AM EDT


Photo Illustration by Luis G. Rendon/The Daily Beast/Getty
https://www.thedailybeast.com/trumps-trial-is...e?ref=home

Welcome to Trail Mix, your 2024 election sanity guide. See something interesting on the trail? Email me at jake.lahut@thedailybeast.com. To get Trail Mix in your inbox, subscribe here for free.

This week, we take an early look at just how much Donald Trump’s Manhattan trial is derailing his campaign.

TRIAL AND ERROR


Even before Donald Trump’s criminal trial in New York began, it was clear that the lengthy and demanding proceedings would fundamentally change his 2024 campaign.

But it only took a few days to show that Trump’s hush money trial will be even more damaging, more constraining, and more significant than anyone expected.


The headlines alone told the story. During the trial’s opening week, for instance, Trump arguably drew the most attention for appearing to fall asleep in the courtroom.

On Tuesday, The Daily Beast reported he was forced to decline an appearance at a big-money fundraiser in Texas for the House GOP because of the trial schedule, an early glimpse at just how much his party leadership will be limited.

And what did happen in court indicated that the trial could drag on even longer than the initial expectation of a two-month timeline—making stunts like Trump’s visit to a Harlem bodega on Tuesday even more likely as the campaign trail sits largely out of reach.

Taken together, Republicans are left with little more than stopgap solutions and, in some cases, a humbling realization of what’s to come—given that the embarrassing details of his alleged plot to pay off porn star Stormy Daniels are yet to emerge.

“I had sort of underestimated just the giant time-suck this is going to be for him as a candidate,” Alex Conant, a GOP strategist and a top aide on Marco Rubio’s 2016 campaign told The Daily Beast.


Crucially, it’s not just time, but money, being left on the table as the hush money case drags on.

“He could be raising six, seven figures pretty regularly at major-dollar events around the country at this point,” Conant said. “That’s literally what Biden is doing. So Trump’s fundraisers are probably frustrated that because he’s in New York, they can’t schedule that stuff.”

Republicans around the Trump campaign are resigning themselves to the new reality of a nominee stuck in court while his rival, President Joe Biden, has the trail largely to himself.

“President Trump’s campaign strategy is obviously going to be a little bit different,” a Trumpworld consultant told The Daily Beast, “but he’s going to put in the energy and time needed to win this election.”

In searching for a silver lining, Trump operatives are resorting to leaning heavily on the old adage that all publicity is good publicity.

As another Trump-aligned GOP strategist put it, at least “he’s getting more earned media than Biden. It’s just wall-to-wall coverage of Trump, Trump, Trump, Trump.”

Yet the Biden campaign doesn’t want to be out front every day competing with Trump for eyeballs over the trial. Instead, the Biden team is looking to silently troll Trump by avoiding direct mentions of the case in favor of blitzing the battleground states to strike a contrast with his record on issues like taxes and abortion.

The split screen highlights what Trump’s biggest loss may ultimately be whenever the trial ends.

“The most valuable commodity in any campaign is the candidate’s time,” Conant said. “It’s the only thing you can’t get more of. And the fact that he’s going to have to spend weeks in the courtroom is time his campaign isn’t going to get back.”

The Trump campaign did not return a request for comment.

After months of holding a lead against Biden in national and battleground state polling—something Trump didn’t enjoy during his runs in 2016 or 2020—the polls have tightened, and Republicans are still coming to grips with how constrained Trump will be for at least the next six to eight weeks, or longer.

Now that the Manhattan trial is underway, Trumpworld is left looking for makeshift alternatives and desperately waiting for something—the prosecution, the optics, anything—to turn public opinion against Democrats. The strategy turns on a cynical assumption: that voters will believe the prosecution from Manhattan District Attorney Alvin Bragg is designed to harm Trump and has the blessing of Biden and Democratic leaders.

“We’re only at day three now, and I think this is gonna have a backfiring effect on Democrats, I really do,” the Trumpworld consultant insisted. “They are interfering with Trump’s ability to get on his plane and go to Pennsylvania, Wisconsin, Michigan, North Carolina, Georgia.”


Trump did that to himself with his clearly indictable behavior you wishful thinking f'ing moron.

Although sources around the Trump campaign said losing ground on fundraising is their biggest concern with the trial, they tried to downplay just how bad the situation could get as the former president continues to get badly outraised by Biden and siphons much of his haul to pay his legal bills.

There’s also a lingering worry that Trump’s courthouse steps routine, a core way of communicating during the trial, will become stale. But the Trump-aligned strategist said they’re not worried about that until “you guys”—meaning the political press—stop covering it so closely.

“I don’t think people are gonna get bored of it, man,” the strategist said. “People never know what he’s gonna fuckin’ say.”

Aside from relying on media coverage of the trial to boost small-dollar fundraising—a copy-and-paste strategy from Trump’s civil cases during the GOP primary—the campaign is also looking at ways to make the most out of the fundraising circuit around New York City during the trial.

“He’s gonna be right here in New York, and there’s a lot of big money here. I’ve also heard rumors of fundraisers in New Jersey and Pennsylvania, too,” the Trump-aligned strategist said.

For the Wednesday and weekend portions of the week when Trump won’t have to be in court, the radius broadens slightly, and he could easily hit rallies in nearby swing states like Pennsylvania and North Carolina, the strategist said. Trump is using his weekend trial break to travel to Wilmington, North Carolina, for a rally on Saturday night.

Early on Friday morning, the Trump campaign announced a late addition to the schedule: a rally in New Jersey on Saturday before he heads down to North Carolina.

Conant likened Trump’s scheduling quandaries to those of a sitting senator running for the presidency. It’s a tradeoff other presidential campaigns have had to deal with before, but unlike missing votes in the Senate, Trump can’t choose to skip court.

“It’s still something every senator who runs for president is challenged by,” Conant said, “and a lot of ’em end up skipping a lot of the votes because your time on the campaign trail is just so valuable.”
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 6

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 7

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 5

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

SAP Launches Sovereign Cloud Solution in Canada for Businesses

Updated Category News Views 365

SAP Enhances Data Security with New Cloud Solutions SAP SE shares are experiencing a positive trend in premarket trading. Recently, SAP Canada introduced its innovative SAP Sovereign Cloud capabilities, which are designed to address the increasing demand from organizations for data sovereignty, robust security, and regulatory compliance. This pioneering solution enables...

Continue Reading
Corbus Pharma's Stock Drops 60%: Analysts Recommend Buying Now

Updated Category News Views 92

Corbus Pharmaceuticals Sees Significant Stock Drop Amid Market Responses Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) has recently faced a dramatic decline in its stock, plummeting by an alarming 60%. However, analysts are encouraging investors to view this as a potential buying opportunity. Firms like H.C. Wainwright and Oppenheimer have reaffirmed their buy...

Continue Reading
Manatt Welcomes New Partner with Extensive Investment Expertise

Updated Category News Views 139

Manatt's Strategic Growth in Corporate Practice Manatt, Phelps & Phillips, LLP is making waves in the corporate legal landscape with its recent addition of Peter Tsirigotis, a seasoned investment funds partner. This move reflects the firm's commitment to expanding its financial services and corporate capabilities. Based in Washington, D.C., Tsirigotis brings a wealth of...

Continue Reading
Performance Share Units Vesting: ISS A/S Updates Details

Updated Category News Views 216

Performance Share Units Vesting Announcement ISS A/S is proud to announce the significant milestone concerning its long-term incentive program (LTIP). As part of this initiative, a number of Performance Share Units (PSUs) have recently vested, leading to the delivery of ISS shares to key personnel within the company. This process, which emphasizes the company's commitment...

Continue Reading
Omnicom Boosts Dividend: New Shareholder Benefit Unveiled

Updated Category News Views 196

Omnicom Boosts Dividend for Shareholders Omnicom, a renowned leader in marketing and sales, has officially announced an increase in its quarterly dividend to $0.80 per share. This enhancement reflects a significant increase in the company's commitment to its shareholders, offering both immediate rewards and a long-term strategy for growth. Dividend Increase Overview The...

Continue Reading